Kim Dekermendjian studied natural sciences at Roskilde University (Denmark) and did his masters thesis in Pharmacology from Linköping University (Sweden) followed by a PhD in medicine from Karolinska Institutet (Sweden).

Kim started his career in academic research at Copenhagen University in Denmark, followed by 2 years as post doctorate at Boston University, USA. Those 10 years in academic research, gave him an extensive knowledge in neuroscience and molecular pharmacology. In 2002, Kim moved to pharmaceutical industry as a project manager and Senior Research Scientist with AstraZeneca R&D in Sweden.

After 8 years Kim had an opportunity with Lundbeck in Denmark as Principal Scientist and project manager. He was leading internal drug discovery projects and projects with both CROs and academic institutions. During his last 2 years with Lundbeck, he has a global role as head of section, leading a team supporting Lundbeck’s ion channel research.

Kim joint CiToxLAB as Business Development & Key Account Manager in 2016. In his position, Kim brings significant expertise pharmacology, drug discovery & development and project management in addition to a long history with pharmaceutical industry.